Two widely used cholesterol medicines offered similar protection against major cardiovascular problems in a three-year trial. However, rosuvastatin was associated with more newly treated diabetes and ...

By Deena Beasley Nov 2 (Reuters) - The recent failure of a Novartis experimental heart drug in a large trial raised questions ...

Scientists finally got a close-up look at the drug and caught it doing something unexpected inside your muscle cells.

Global cardiometabolic drugs market size to grow USD 551.46 Billion by 2035, at a CAGR of 9.11% during the forecast period 2026–2035 ...

I went on a year-long journey of testing blood panels from Apple, Oura, Whoop and Ultrahuman, expecting boring results.

A basic cholesterol panel doesn’t measure this certain inherited factor that can raise your risk for heart disease.

Hello. I am Lily, a cardiologist. During health checkup consultations, I often hear this from women in their 50s. 'It was always normal, but suddenly I was told my LDL is high.' 'My diet hasn't ...

Analysis of over 387,000 patients shows type‑2 diabetes medications can trigger side‑effects that lead to further drug prescriptions, raising concerns about polypharmacy. Researchers examined two ...

After 26 years in genomics, entrepreneur Anu Acharya is betting that the future of health care lies not just in treating disease but in identifying risks before they become illnesses. As founder and ...

LIB Therapeutics, Inc. (LIB), a privately held biopharmaceutical company with a singular focus on helping high-risk patients ...

125 nmol/L (about 50 mg/dL) or higher: elevated. This is the cut-off the American Heart Association, the National Lipid Association and the European Atherosclerosis Society all use. Mine is 201.

A tailored health coach intervention significantly reduces low-density lipoprotein cholesterol levels in veterans with cardiovascular disease.